Octostim
Octostim is a medicine authorised by Swissmedic under authorisation number 53745. The authorisation holder is Ferring AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 20 June 1997 and the authorisation is valid without a time limit. ATC code H01BA02 places the medicine in the group Pituitary and hypothalamic hormones and analogues.
| Authorisation number | 53745 |
|---|---|
| Name | Octostim |
| Full name | Octostim, Nasenspray, Lösung |
| Authorisation holder | Ferring AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | H01BA02 |
| First authorisation | 20 June 1997 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Octostim, Nasenspray, Lösung | B | 27 January 1999 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 24 | 2,5 | ml | H01BA02 | 06.02.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Octostim authorised in Switzerland?
Yes. Octostim is authorised by Swissmedic under authorisation number 53745, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Octostim have?
Octostim is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Octostim?
The authorisation holder is Ferring AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.